Tag Archives: Dr Carina Ämmälä

AstraZeneca/ Karolinska Institutet research points to novel targets for next generation medicines for type 2 diabetes, obesity and other metabolic disorders

STOCKHOLM, 27-Sep-2016 — /EuropaWire/ — New understanding of how hormone-producing cells in the pancreas decode their genetic instructions is pointing to novel targets for next generation medicines for type 2 diabetes, obesity and other metabolic disorders. A large scale analysis of … Read the full press release